Skip to main content
. Author manuscript; available in PMC: 2020 Apr 10.
Published in final edited form as: Hematol Oncol Clin North Am. 2019 Feb;33(1):103–120. doi: 10.1016/j.hoc.2018.09.001

Table 1.

Mycosis fungoides variants recognized by the World Health Organization/European Organization for Research and Treatment of Cancer

MF Subtype Clinical Presentation Immunophenotype Histology
Folliculotropic MF Predilection for head/neck
Alopecic skin lesions
Follicular papules; Acneiform/comedonal-like papules or nodules (see Fig. 4)
CD41CD31 T-cell
Admixed CD30 1 blasts
Perivascular and periadenexal lymphocytic infiltrates with infiltration of follicular epithelium (folliculotropism); variable infiltration of eccrine sweat glands by atypical lymphocytes with sparing of epidermis; follicular mucinosis
Pagetoid reticulosis Predilection for extremities
Localized psoriasiform patch or plaque
Indolent clinical behavior
CD41CD31 T-cell or CD81CD31 T-cell
CD30 often positive
Hyperplastic epithelium with marked pagetoid-like atypical lymphocytes; dermis with mixed reactive lymphocytes and histiocytes
Granulomatous slack skin Predilection from axillae and groin
Lax pendulous skin
Indolent clinical behavior
CD41CD31 T-cell Dense granulomatous dermal infiltrates of atypical lymphocytes, macrophages, many multinucleated giants cells; destruction of elastic tissue

Data from Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005;105(10):3768–85.